Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 23:8:737079.
doi: 10.3389/fmed.2021.737079. eCollection 2021.

Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk

Affiliations
Review

Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk

Lucia Novelli et al. Front Med (Lausanne). .

Abstract

Psoriatic arthritis (PsA) is a chronic inflammatory disease primarily affecting peripheral and axial joints, with the possible presence of extra-articular manifestations (EAMs), such as psoriasis, uveitis, and inflammatory bowel disease. Recently, the concept of psoriatic disease (PsD) has been proposed to define a systemic condition encompassing, in addition to joints and EAMs, some comorbidities (e.g., metabolic syndrome, type II diabetes, hypertension) that can affect the disease outcome and the achievement of remission. EAMs and comorbidities in PsA share common immunopathogenic pathways linked to the systemic inflammation of this disease; these involve a broad variety of immune cells and cytokines. Currently, various therapeutics are available targeting different cytokines and molecules implicated in the inflammatory response of this condition; however, despite an improvement in the management of PsA, comprehensive disease control is often not achievable. There is, therefore, a big gap to fill especially in terms of comorbidities and EAMs management. In this review, we summarize the clinical aspects of the main comorbidities and EAMs in PsA, and we focus on the immunopathologic features they share with the articular manifestations. Moreover, we discuss the effect of a diverse immunomodulation and the current unmet needs in PsD.

Keywords: comorbidities; extra-articular manifestations; immunomodulation; psoriatic arthritis; psoriatic disease; systemic inflammation.

PubMed Disclaimer

Conflict of interest statement

FM, LN, and GC, are AbbVie employees and may own AbbVie stocks/options. FI has received consultancy fees and/or speaker honoraria from Actelion, Pfizer, AbbVie, Janssen, Celgene, Novartis, MSD, BMS, UCB, Sobi, Roche, Sanofi outside this work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
PsA key cytokines involved in comorbidities and EAMs pathogenesis. CV, cardiovascular; EAM, extra-articular manifestation; IBD, inflammatory bowel disease; IFN-γ, interferon; IL, interleukin; PsA, psoriatic arthritis; TNF, tumor necrosis factor. Created with Biorender.com.
Figure 2
Figure 2
The JAK/STAT pathway involvement in different diseases. IBD, inflammatory bowel disease; JAK, Janus kinase; P, phosphate; STAT, signal transducer and activator of transcription. Created with Biorender.com.

Similar articles

Cited by

References

    1. Helliwell PS. Verna Wright: father of the spondyloarthropathies. Ann Rheum Dis. (2019) 78:454–5. 10.1136/annrheumdis-2018-214689 - DOI - PubMed
    1. Coates LC, Helliwell PS. Psoriatic arthritis: state of the art review. Clin Med. (2017) 17:65–70. 10.7861/clinmedicine.17-1-65 - DOI - PMC - PubMed
    1. Pittam B, Gupta S, Harrison NL, Robertson S, Hughes DM, Zhao SS. Prevalence of extra-articular manifestations in psoriatic arthritis: a systematic review and meta-analysis. Rheumatology. (2020) 59:2199–206. 10.1093/rheumatology/keaa062 - DOI - PubMed
    1. Gupta S, Syrimi Z, Hughes DM, Zhao SS. Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatol Int. (2021) 41:275–84. 10.1007/s00296-020-04775-2 - DOI - PMC - PubMed
    1. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum. (2009) 61:233–9. 10.1002/art.24172 - DOI - PMC - PubMed